Report Company Directory

Logic Instrument S.A.

• LOGIC INSTRUMENT - Résultats 2025: Pression sur la marge brute en fin d’année / Opinion: Achat / Objectif: 2,82€ / Potentiel: +27,6% by GreenSome Finance
• LOGIC INSTRUMENT - CA 2025: 39 M€, +42%, Objectif 75 M€ pour 2026 / Opinion: Achat / Objectif: 2,89€ / Potentiel: +61,4% by GreenSome Finance
• LOGIC INSTRUMENT - Nouvelle feuille de route stratégique / Opinion: Achat / Objectif: 2,89€ / Potentiel: +68,5% by GreenSome Finance
• LOGIC INSTRUMENT - Nouvelle opération de croissance externe / Opinion: Achat / Objectif: 2,89€ / Potentiel: +67,5% by GreenSome Finance
• LOGIC INSTRUMENT - RN S1: Forte amélioration des résultats - Mex de 7,7%, +0,6 pt / Opinion: Achat / Objectif: 2,60€ / Potentiel: +20,4% by GreenSome Finance
• LOGIC INSTRUMENT - CA S1: 19,3 M€, +32% / Opinion: Achat / Objectif: 2,60€ / Potentiel: +26,2% by GreenSome Finance
• LOGIC INSTRUMENT- Nette amélioration de la rentabilité / Opinion: Achat / Objectif: 2,60€ vs 2,49€/ Potentiel: +36,1% by GreenSome Finance
• LOGIC INSTRUMENT- Acquisition de Glacier Computer / Opinion: Achat / Objectif: 2,49€ vs 1,93€/ Potentiel: +51,6% by GreenSome Finance
• LOGIC INSTRUMENT- CA 2024: 27,4 M€, +68% Inférieur à notre attente - Confiance pour 2025 / Opinion: Achat/ Objectif: 1,93€ vs 1,73€/ Potentiel: +71,6% by GreenSome Finance
• LOGIC INSTRUMENT: Nouvelle acquisition / Opinion: Achat / Objectif: 1,73€ / Potentiel: +99,8% by GreenSome Finance

LOGICA VENTURES CORP

LogiCamms Ltd.

• Feasibility Study Results in December to be a Catalyst for this Junior by Fundamental Research
• Ford Equity International Rating and Forecast Report by Ford Equity Research

LogicBio Therapeutics

• AASLD 2022 Recap: ALBO, ALNY, IONS, and VACC Highlights and Other Industry Updates by William Blair
• Dropping Coverage Following Completion of Acquisition by William Blair
• Shipping Up to SITC: Highlights From the Society for Immunotherapy of Cancer Annual Meeting by William Blair
• LogicBio Therapeutics, Inc.: Discontinuing Coverage by Barclays
• Getting Into (Bi)Specifics Discussion Hosted by Matt Phipps, Ph.D., on Friday, November 18 at 11:00 a.m. EST by William Blair
• Getting Into (Bi)Specifics by William Blair
• Fast Forward No. 625 by William Blair
• REMINDER Today: Taking the Pulse on Biogen by William Blair
• Taking the Pulse on Biogen by William Blair
• Fast Forward No. 624 by William Blair

LOGICMARK INC

• LogicMark, Inc. Announces Strong Fourth Quarter and Full Year 2025 Results by GlobeNewsWire
• LogicMark, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026 by GlobeNewsWire
• LogicMark, Inc. Announces Third Quarter 2025 Results by GlobeNewsWire
• LogicMark, Inc. to Announce Third Quarter 2025 Financial Results on November 12, 2025 by GlobeNewsWire
• LogicMark Launches Predictive Activity Metrics in Freedom Alert Max Device by GlobeNewsWire
• LogicMark Becomes First to Integrate Medication Reminders into Medical Alert Technology by GlobeNewsWire
• Walking Alone at Night is the Greatest Safety Fear of Women Nationwide -- Almost Half Say Safety Concerns Limit Daily Activities LogicMark Poll Reveals by GlobeNewsWire
• LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth by GlobeNewsWire
• LogicMark, Inc. to Announce Second Quarter 2025 Financial Results on August 12, 2025 by GlobeNewsWire
• LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets by GlobeNewsWire